© Juan Carlos Tomasi
Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.
Overcoming Barriers to Access
Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.
19. December 2011
PATENT POOL
MSF reviews Gilead's licences to Medicines Patent Pool
MSF takes a deeper look at the Gilead licences to the Patent Pool from July 2011, as well as the benefits and limitations of voluntary licensing more generally.
Zimbabwe 2011 © Brendan Bannon
Access Barriers: The Issues
Access Barriers: The Issues
Featured multimedia
UN Rapporteur supports MSF's "Hands Off" Campaign
UN Special Rapporteur on the Right to Health Anand Grover describes just how critical India's role in providing generic medicines to developing countries around the world...
Recent news
MSF & Patents
MSF & Patents
© Julie Remy
MSF created the Access Campaign to help get our patients the best possible treatment which includes looking at the political and commercial barriers that stand in the way of access to affordable medicine.
Overcoming Barriers to Access Facts
Thanks to generic competition, the price of ARVs fell from more than $10,000 per patient per year in 2000, to $67 today
↑ To top